<?xml version="1.0" encoding="UTF-8" ?> 

<rss version="2.0"> 
<channel> 
<title>Alternative Therapies News</title> 
<link>http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/406</link> 
<description>Alternative Therapies</description> 
<language>en-us</language> 
<copyright>Copyright 2009 MDLinx, Inc.</copyright>










 



<item> 
<title><![CDATA[Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions]]></title> 
<link>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943339</link> 
<pubDate>11/9/2009</pubDate> 
<description><![CDATA[<b>Cancer Prevention Research</b>]]></description> 
<guid>http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943339</guid>
</item> 


 
 


  


</channel> 
</rss>

